Evolve CSO to Present at Annual Microbiome Summit Sept 21-22
Annual Microbiome Summit: Translating into Diagnostics and BioTherapeutics Summit.
Vienna, Austria. September 21, 22 2017.
On September 22, Dr. David Kyle, Chairman and Chief Science Officer of Evolve BioSystems will present: Rescuing the Infant Gut Microbiome.
Dr. Kyle will walk the audience through Evolve's current clinical research, and how activated B. infantis EVC001 can restore the newborn gut microbiome. The trillions of bacteria that live within the intestinal tract of newborns play a critical role in proper immune and metabolic development as well as meeting the newborn’s nutritional needs. Disruption of the newborn gut microbiome can cause both acute and chronic health consequences. Based on novel discoveries of the unique partnership between mammalian milk and a key intestinal bacterium, Evolve has pioneered a microbiome-based approach to solving newborn gut dysbiosis.
For more details on the Annual Microbiome Summit, visit the conference website here.
Evolve BioSystems Contact
Dr. Tracy Shafizadeh
Director, Scientific Communications